Skip to main content

Table 3 Hepatitis B virus and hepatitis C virus serological status

From: Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors

 

Total (n = 388) [n (%)]

HBV exposed

33 (8.5)

Chronic HBV infection a

1 (0.3)

Past HBV infection

32 (8.3)

  Isolated anti-HBc b

8 (2.0)

  Anti-HBc (+) and

24 (6.2)

  anti-HBs (+) c

 

HBV vaccine d

56 (14.4)

HBV negative e

299 (77.0)

HCV positive

5 (1.3)

HCV negative

383 (98.7)

  1. HBV: hepatitis B virus; HCV: hepatitis C virus
  2. a HBsAg (+), anti-HBc (+), anti-HBs (−) b HBsAg (−), anti-HBc (+), anti-HBs (−) c HBsAg (−), anti-HBc (+), anti-HBs (+) d HBsAg (−), anti-HBc (−), anti-HBs (+) [anti-HBs ≥ 10 IU/mL] e HBsAg (−), anti-HBc (−), anti-HBs (−)